SCHEMBL527423

SCHEMBL527423

CC(C)C(=O)CC(=O)O.[Ag]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.44
SRR Q9GZT4 1/20 0.44
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
PTGS2 P35354 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
FFAR3 O14843 1/20 0.35
GABRP O00591 2/20 0.35
GABRD O14764 2/20 0.35
GABRA1 P14867 2/20 0.35
GABRB1 P18505 2/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRA3 P34903 2/20 0.35
GABRA2 P47869 2/20 0.35
GABRB2 P47870 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL517270 0.97
Ammonia Solution, Strong SCHEMBL14935478 0.94 LDHA (0.44) LDHASRRCYP2D6CYP2C19ALDH1A1
SCHEMBL28121726 0.87 LDHA (0.38) LDHASRRCYP2D6CYP2C19ALDH1A1
SCHEMBL11635650 0.85 LDHA (0.36) LDHASRRCYP2D6CYP2C19ALDH1A1
SCHEMBL9292454 0.83 LDHA (0.40) LDHASRRCYP2D6CYP2C19ALDH1A1
SCHEMBL181668 0.81 CYP2D6 (0.36) CYP2D6CYP2C19ALDH1A1TDP1TP53
SCHEMBL9282807 0.78 CYP2D6 (0.35) CYP2D6CYP2C19ALDH1A1TDP1TP53
SCHEMBL29035568 0.78 CYP2D6 (0.35) CYP2D6CYP2C19ALDH1A1TDP1TP53
SCHEMBL30534795 0.78 CYP2D6 (0.35) CYP2D6CYP2C19ALDH1A1TDP1TP53
SCHEMBL30534812 0.78 CYP2D6 (0.35) CYP2D6CYP2C19ALDH1A1TDP1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10040960-B2 Silver ink composition, conductor and communication device TOPPAN FORMS CO., LTD. (JP) 2018-08-07 US claimed
EP-2599840-B1 SILVER INK COMPOSITION AND BASE MATERIAL TOPPAN FORMS CO LTD (JP) 2018-07-25 EP claimed
US-9371465-B2 Silver ink composition TOPPAN FORMS CO., LTD. (JP) 2016-06-21 US claimed
US-9328254-B2 Silver ink composition and substrate TOPPAN FORMS CO., LTD. (JP) 2016-05-03 US claimed
US-20150259557-A1 SILVER INK COMPOSITION, CONDUCTOR AND COMMUNICATION DEVICE TOPPAN FORMS CO., LTD (JP) 2015-09-17 US claimed
US-20150008376-A1 Silver Ink Composition TOPPAN FORMS CO., LTD (JP) 2015-01-08 US claimed
EP-2599840-A1 SILVER INK COMPOSITION AND BASE MATERIAL Toppan Forms Co., Ltd. (JP) 2013-06-05 EP claimed
US-20130121872-A1 Silver Ink Composition and Substrate TOPPAN FORMS CO., LTD. (JP) 2013-05-16 US claimed
EP-1905756-B1 SILVER BETA-KETOCARBOXYLATE DERIVATIVES FOR FORMING SILVER METAL UNIV OSAKA (JP) 2013-02-27 EP claimed
US-7683195-B2 Silver β-ketocarboxylate, material comprising the same for forming silver metal, and use thereof Osaka Industrial Promotional Organization (JP) 2010-03-23 US claimed
US-20090209693-A1 Silver Beta-Ketocarboxylate, Material Comprising the Same for Forming Silver Metal, and Use Thereof OSAKA INDUSTRIAL PROMOTION (JP) 2009-08-20 US claimed
EP-1905756-A1 SILVER BETA-KETOCARBOXYLATE, MATERIAL COMPRISING THE SAME FOR FORMING SILVER METAL, AND USE THEREOF OSAKA UNIVERSITY (JP) 2008-04-02 EP claimed
US-12427714-B2 Functionalized product fabricated from a resin comprising a functional component and a polymeric resin, and method of making the same NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2025-09-30 US disclosed
US-12360294-B2 3D printed graded refractive index device CARLETON UNIVERSITY (CA) 2025-07-15 US disclosed
US-12119131-B2 Method for synthesizing copper-silver alloy, method for forming conduction part, copper-silver alloy, and conduction part SENJU METAL INDUSTRY CO., LTD. (JP) 2024-10-15 US disclosed
US-12017392-B2 Overmoulded printed electronic parts and methods for the manufacture thereof NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2024-06-25 US disclosed
US-20090209693-A1 Silver Beta-Ketocarboxylate, Material Comprising the Same for Forming Silver Metal, and Use Thereof OSAKA INDUSTRIAL PROMOTION (JP) 2009-08-20 US disclosed
EP-1905756-A1 SILVER BETA-KETOCARBOXYLATE, MATERIAL COMPRISING THE SAME FOR FORMING SILVER METAL, AND USE THEREOF OSAKA UNIVERSITY (JP) 2008-04-02 EP disclosed
EP-1905756-A1 SILVER BETA-KETOCARBOXYLATE, MATERIAL COMPRISING THE SAME FOR FORMING SILVER METAL, AND USE THEREOF OSAKA UNIVERSITY (JP) 2008-04-02 EP disclosed
WO-2007004437-A1 SILVER β-KETOCARBOXYLATE, MATERIAL COMPRISING THE SAME FOR FORMING SILVER METAL, AND USE THEREOF OSAKA INDUSTRIAL PROMOTION ORGANIZATION (JP) 2007-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209693-A1 Silver Beta-Ketocarboxylate, Material Comprising the Same for Forming Silver Metal, and Use Thereof PCCA, BCKDK, MCCC2 LDHA 47/4885SRR 3369/4885CYP2D6 1462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.